572 results on '"Gebauer, Florian"'
Search Results
2. Robotic-assisted versus laparoscopic-assisted extended mesorectal excision: a comprehensive meta-analysis and systematic review of perioperative and long-term outcomes
3. QUIC Hunter: Finding QUIC Deployments and Identifying Server Libraries Across the Internet
4. QUIC Hunter: Finding QUIC Deployments and Identifying Server Libraries Across the Internet
5. Impact of structured surveillance of patients with esophageal cancer following surgical resection with curative intent
6. Long-Term Postsurgical Outcomes of Neoadjuvant Chemoradiation (CROSS) Versus Chemotherapy (FLOT) for Multimodal Treatment of Adenocarcinoma of the Esophagus and the Esophagogastric Junction
7. The role of length of oral resection margin and survival in esophageal cancer surgery after neoadjuvant therapy: A retrospective propensity score-matched study
8. QUIC Hunter: Finding QUIC Deployments and Identifying Server Libraries Across the Internet
9. Dissecting the inflammatory tumor microenvironment of esophageal adenocarcinoma: mast cells and natural killer cells are favorable prognostic factors and associated with less extensive disease
10. Biomarker screen for efficacy of oncolytic virotherapy in patient-derived pancreatic cancer cultures
11. FGFR2-amplified tumor clones are markedly heterogeneously distributed in carcinomas of the upper gastrointestinal tract
12. The tight junction protein claudin 6 is a potential target for patient-individualized treatment in esophageal and gastric adenocarcinoma and is associated with poor prognosis
13. Parameters predicting postoperative pain and quality of life after hemorrhoidectomy: follow-up results from a prospective multicenter randomized trial
14. Tumour area infiltration and cell count in endoscopic biopsies of therapy-naive upper GI tract carcinomas by QuPath analysis: implications for predictive biomarker testing
15. Tumor cell integrin β4 and tumor stroma E-/P-selectin cooperatively regulate tumor growth in vivo
16. Predicting the HER2 status in oesophageal cancer from tissue microarrays using convolutional neural networks
17. ASO Visual Abstract: Long-Term Postsurgical Outcomes of Neoadjuvant Chemoradiation (CROSS) Versus Chemotherapy (FLOT) for Multimodal Treatment of Adenocarcinoma of the Esophagus and the Esophagogastric Junction
18. Artificial intelligence for tumour tissue detection and histological regression grading in oesophageal adenocarcinomas: a retrospective algorithm development and validation study
19. Fructose-1,6-bisphosphatase 1 (FBP1) is an independent biomarker associated with a favorable prognosis in esophageal adenocarcinoma
20. Long-Term Outcome After Histopathological Complete Response with and Without Nodal Metastases Following Multimodal Treatment of Esophageal Cancer
21. Phase-II-Studie zur multimodalen Therapie beim hepatisch oligometastasierten Adenokarzinom des Pankreas
22. Expression of Neighbor of Punc E11 (NOPE) in early stage esophageal adenocarcinoma is associated with reduced survival
23. Integrin beta1 (ITGB1) as a prognostic marker in esophageal adenocarcinoma
24. Challenges in Robotic and Minimally Invasive Pancreatic Surgery in the Year 2020
25. The Role of Surgery in Oligo-Metastatic Pancreatic Cancer
26. The Hallmarks of Pancreatic Cancer
27. Sex-specific prognostic effect of CD66b-positive tumor-infiltrating neutrophils (TANs) in gastric and esophageal adenocarcinoma
28. PIK3CA and KRAS Amplification in Esophageal Adenocarcinoma and their Impact on the Inflammatory Tumor Microenvironment and Prognosis
29. Tumor biology and multidisciplinary strategies of oligometastasis in gastrointestinal cancers
30. Analyzing the Impact of Oncological Data at Different Time Points and Tumor Biomarkers on Artificial Intelligence Predictions for Five-Year Survival in Esophageal Cancer
31. GATA binding protein 6 (GATA6) is co-amplified with PIK3CA in patients with esophageal adenocarcinoma and is linked to neoadjuvant therapy
32. Tumor budding assessed according to the criteria of the International Tumor Budding Consensus Conference determines prognosis in resected esophageal adenocarcinoma
33. Lymphocyte activation gene-3 (LAG3) mRNA and protein expression on tumour infiltrating lymphocytes (TILs) in oesophageal adenocarcinoma
34. True single-port cholecystectomy with ICG cholangiography through a single 15-mm trocar using the new surgical platform “symphonX”: first human case study with a commercially available device
35. Immune profile and immunosurveillance in treatment-naive and neoadjuvantly treated esophageal adenocarcinoma
36. Endoscopic vacuum therapy versus stent treatment of esophageal anastomotic leaks (ESOLEAK): study protocol for a prospective randomized phase 2 trial
37. Integrin alpha-V is an important driver in pancreatic adenocarcinoma progression
38. Study protocol of an open-label, single arm phase II trial investigating the efficacy, safety and quality of life of neoadjuvant chemotherapy with liposomal irinotecan combined with Oxaliplatin and 5-fluorouracil/Folinic acid followed by curative surgical resection in patients with hepatic Oligometastatic adenocarcinoma of the pancreas (HOLIPANC)
39. High levels of RAI3 expression is linked to shortened survival in esophageal cancer patients
40. Surgical and multimodal treatment of metastatic oesophageal cancer: retrospective cohort study.
41. Genomic Characterization of TP53–Wild-Type Esophageal Carcinoma
42. Combined score of Y chromosome loss and T-cell infiltration improves UICC based stratification of esophageal adenocarcinoma
43. Strukturierte Befundung und standardisiertes Therapiemonitoring
44. Aberrant expression of Sec61α in esophageal cancers
45. Stellenwert der Metastasenchirurgie beim fortgeschrittenen Pankreaskarzinom
46. Parameters predicting postoperative pain and quality of life after hemorrhoidectomy: follow-up results from a prospective multicenter randomized trial
47. Failure of a Multi-Centric Clinical Trial Investigating Neoadjuvant Radio-Chemotherapy in Resectable Pancreatic Carcinoma (NEOPA-NCT01900327)—Which Lessons Are Learnt?
48. Prediction of five-year survival of patients with esophageal cancer and the effect of biomarkers on predictive performance using Artificial Intelligence
49. Integrin alpha V (ITGAV) expression in esophageal adenocarcinoma is associated with shortened overall-survival
50. Interferon-Induced Protein With Multiple Tetratricopeptide Repeats 3 Is Associated With Response to Chemotherapy and Recurrence but Not With Survival
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.